Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSEN1 | P49768 | 14/20 | 0.47 |
| ▸ | PSEN2 | P49810 | 14/20 | 0.47 |
| ▸ | APH1B | Q8WW43 | 14/20 | 0.47 |
| ▸ | NCSTN | Q92542 | 14/20 | 0.47 |
| ▸ | APH1A | Q96BI3 | 14/20 | 0.47 |
| ▸ | PSENEN | Q9NZ42 | 14/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | GSAP | A4D1B5 | 1/20 | 0.43 |
| ▸ | REN | P00797 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14876684 | 1.00 | PSEN1 (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL23476580 | 1.00 | PSEN1 (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL1360317 | 1.00 | PSEN1 (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL14886930 | 0.89 | CYP3A4 (0.48) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL18642504 | 0.86 | CYP3A4 (0.51) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL28186177 | 0.86 | CYP3A4 (0.51) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL5966881 | 0.84 | KLK5 (0.48) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL16490908 | 0.84 | PSEN1 (0.45) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL5967121 | 0.84 | REN (0.44) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL4057116 | 0.84 | PSEN1 (0.42) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2845 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747363-A1 | NEURAL DIFFERENTIATION FROM PLURIPOTENT CELLS | Treefrog Therapeutics (FR) | 2026-05-27 | — | — | EP | claimed |
| CN-121526349-B | Dynamic risk management method and system for traffic engineering construction | XIAMEN ROAD & BRIDGE INFORMATION Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12629337-B2 | Daptomycin formulation | HIKMA PHARMACEUTICALS USA INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20260132374-A1 | Compositions and Methods for Efficient Amplification of Retinal Progenitors Cells | SORBONNE UNIVERSITE (FR) | 2026-05-14 | — | — | US | claimed |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| US-12618044-B2 | Specification of functional cranial placode derivatives from human pluripotent stem cells | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-05-05 | — | — | US | claimed |
| WO-2026089437-A1 | LIVER TISSUE-LIKE ORGANOID AND METHOD OF MANUFACTURING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2026-04-30 | — | — | WO | claimed |
| WO-2026088216-A1 | METHOD OF GENERATING LIVER ORGANOID MODEL AND MODEL RECAPITULATING NAFLD HALLMARKS | TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE (IN) | 2026-04-30 | — | — | WO | claimed |
| US-20260117188-A1 | LIVER TISSUE-LIKE ORGANOID AND METHOD OF MANUFACTURING THE SAME | KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) | 2026-04-30 | — | — | US | claimed |
| EP-4720261-A1 | NOVEL CULTURE CONDITIONS FOR CLONAL EXPANSION OF NEPHRON PROGENITOR CELLS, GENERATION OF NEPHRON ORGANOIDS, AND RAPID AND SCALABLE MODELING OF POLYCYSTIC KIDNEY DISEASE | University of Southern California (US) | 2026-04-08 | — | — | EP | claimed |
| US-20220062291-A1 | COMPOSITIONS AND METHODS OF TREATING CANCERS BY ADMINISTERING A PHENOTHIAZINE-RELATED DRUG THAT ACTIVATES PROTEIN PHOSPHATASE 2A (PP2A) WITH REDUCED INHIBITORY ACTIVITY TARGETED TO THE DOPAMINE D2 RECEPTOR AND ACCOMPANYING TOXICITY | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-03-03 | — | — | US | claimed |
| EP-3959306-A1 | NOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | The United States of America as represented by the Secretary of the Department of Health and Human Services (US) | 2022-03-02 | — | — | EP | claimed |
| CN-114096557-A | Generation of germ layer cells in the dorsal foregut and anterior structural domains | 克利夫兰诊所基金会 | 2022-02-25 | — | — | CN | claimed |
| EP-3303564-B1 | METHODS OF IN VITRO DIFFERENTIATION OF MIDBRAIN DOPAMINE (MDA) NEURONS | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-02-23 | — | — | EP | claimed |
| US-11254916-B2 | Methods of making and using PDX1-positive pancreatic endoderm cells | VIACYTE, INC. (US) | 2022-02-22 | — | — | US | claimed |
| CN-111500526-B | Composition for in-vitro culture of primary mouse corneal epithelial cells and application thereof | 厦门大学 | 2022-02-18 | — | — | CN | claimed |
| US-20220041990-A1 | METHODS, COMPOSITIONS, AND KITS FOR PRODUCING SKELETAL MUSCLE STEM CELLS AND TREATING DISORDERS | UNIV JOHNS HOPKINS (US) | 2022-02-10 | — | — | US | claimed |
| EP-3945827-A2 | METHODS, COMPOSITIONS, AND KITS FOR PRODUCING SKELETAL MUSCLE STEM CELLS AND TREATING DISORDERS | The Johns Hopkins University (US) | 2022-02-09 | — | — | EP | claimed |
| WO-2022026932-A2 | DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-02-03 | — | — | WO | claimed |
| CN-110582564-A | derivation of liver organoids from human pluripotent stem cells | 新加坡科技研究局 | 2019-12-17 | — | — | CN | claimed |